CHA News

Telehealth Prescribing Flexibilities for Some Medications Extended

This post has been archived and contains information that may be out of date.

The Drug Enforcement Administration and the Substance Abuse and Mental Health Services Administration have issued a temporary rule that extends telehealth prescribing flexibilities for buprenorphine and other controlled substances through Nov. 11, 2024.  

This extension allows the telehealth prescribing flexibilities that were adopted during the COVID-19 public health emergency (PHE) to remain in effect past the end of the PHE while the agencies develop final regulations.